Artery Research
Volume 2, Issue 4 , Pages 148-155 , November 2008

Genetic variation in the C-reactive protein gene and arterial stiffness: The Rotterdam Study

  • M.P.S. Sie

      Affiliations

    • Department of Epidemiology & Biostatistics, Erasmus Medical Center, P.O. Box 2040, 3000 CA Rotterdam, the Netherlands
    • Department of Internal Medicine, Erasmus Medical Center, Rotterdam, the Netherlands
    • ,
  • F.U.S. Mattace-Raso

      Affiliations

    • Department of Epidemiology & Biostatistics, Erasmus Medical Center, P.O. Box 2040, 3000 CA Rotterdam, the Netherlands
    • Department of Internal Medicine, Erasmus Medical Center, Rotterdam, the Netherlands
    • ,
  • I. Kardys

      Affiliations

    • Department of Epidemiology & Biostatistics, Erasmus Medical Center, P.O. Box 2040, 3000 CA Rotterdam, the Netherlands
    • ,
  • M.P.M. de Maat

      Affiliations

    • Department of Haematology, Erasmus Medical Center, Rotterdam, the Netherlands
    • ,
  • A.G. Uitterlinden

      Affiliations

    • Department of Epidemiology & Biostatistics, Erasmus Medical Center, P.O. Box 2040, 3000 CA Rotterdam, the Netherlands
    • Department of Internal Medicine, Erasmus Medical Center, Rotterdam, the Netherlands
    • ,
  • A. Hofman

      Affiliations

    • Department of Epidemiology & Biostatistics, Erasmus Medical Center, P.O. Box 2040, 3000 CA Rotterdam, the Netherlands
    • ,
  • A.P.G. Hoeks

      Affiliations

    • Department of Biophysics (A.P.G.H.), Cardiovascular Research Institute Maastricht, Maastricht University, Maastricht, the Netherlands
    • ,
  • R.S. Reneman

      Affiliations

    • Departments of Physiology (R.S.R.), Cardiovascular Research Institute Maastricht, Maastricht University, Maastricht, the Netherlands
    • ,
  • R. Asmar

      Affiliations

    • Cardiovascular Institute, Paris, France
    • ,
  • C.M. van Duijn

      Affiliations

    • Department of Epidemiology & Biostatistics, Erasmus Medical Center, P.O. Box 2040, 3000 CA Rotterdam, the Netherlands
    • ,
  • J.C.M. Witteman

      Affiliations

    • Department of Epidemiology & Biostatistics, Erasmus Medical Center, P.O. Box 2040, 3000 CA Rotterdam, the Netherlands
    • Corresponding Author InformationCorresponding author. Tel.: +31 10 708 7488; fax: +31 10 708 9382.

Received 30 May 2008 ,Revised 13 October 2008 ,Accepted 16 October 2008.

References 

  1. Avolio AP, Chen SG, Wang RP, Zhang CL, Li MF, O'Rourke MF. Effects of aging on changing arterial compliance and left ventricular load in a northern Chinese urban community. Circulation. 1983;68:50–58
  2. Roman MJ, Saba PS, Pini R, Spitzer M, Pickering TG, Rosen S, et al. Parallel cardiac and vascular adaptation in hypertension. Circulation. 1992;86:1909–1918
  3. Girerd X, Mourad JJ, Copie X, Moulin C, Acar C, Safar M, et al. Noninvasive detection of an increased vascular mass in untreated hypertensive patients. Am J Hypertens. 1994;7:1076–1084
  4. London GM, Marchais SJ, Safar ME, Genest AF, Guerin AP, Metivier F, et al. Aortic and large artery compliance in end-stage renal failure. Kidney Int. 1990;37:137–142
  5. Wada T, Kodaira K, Fujishiro K, Maie K, Tsukiyama E, Fukumoto T, et al. Correlation of ultrasound-measured common carotid artery stiffness with pathological findings. Arterioscler Thromb. 1994;14:479–482
  6. van Popele NM, Grobbee DE, Bots ML, Asmar R, Topouchian J, Reneman RS, et al. Association between arterial stiffness and atherosclerosis: The Rotterdam study. Stroke. 2001;32:454–460
  7. Mattace-Raso FU, van der Cammen TJ, Hofman A, van Popele NM, Bos ML, Schalekamp MA, et al. Arterial stiffness and risk of coronary heart disease and stroke: The Rotterdam study. Circulation. 2006;113:657–663
  8. Boutouyrie P, Tropeano AI, Asmar R, Gautier I, Benetos A, Lacolley P, et al. Aortic stiffness is an independent predictor of primary coronary events in hypertensive patients: a longitudinal study. Hypertension. 2002;39:10–15
  9. Franklin SS, Khan SA, Wong ND, Larson MG, Levy D. Is pulse pressure useful in predicting risk for coronary heart disease? The Framingham heart study. Circulation. 1999;100:354–360
  10. Benetos A, Safar M, Rudnichi A, Smulyan H, Richard JL, Ducimetieere P, et al. Pulse pressure: A predictor of long-term cardiovascular mortality in a French male population. Hypertension. 1997;30:1410–1415
  11. Kullo IJ, Seward JB, Bailey KR, Bielak LF, Grossardt BR, Sheedy PF, et al. C-reactive protein is related to arterial wave reflection and stiffness in asymptomatic subjects from the community. Am J Hypertens. 2005;18:1123–1129
  12. Vlachopoulos C, Dima I, Aznaouridis K, Vasiliadou C, Ioakeimidis N, Aggeli C, et al. Acute systemic inflammation increases arterial stiffness and decreases wave reflections in healthy individuals. Circulation. 2005;112:2193–2200
  13. Tomiyama H, Koji Y, Yambe M, Motobe K, Shiina K, Gulnisa Z, et al. Elevated C-reactive protein augments increased arterial stiffness in subjects with the metabolic syndrome. Hypertension. 2005;45:997–1003
  14. Mattace-Raso FU, van der Cammen TJ, van der Meer IM, Schalekamp MA, Asmar R, Hofman A, et al. C-reactive protein and arterial stiffness in older adults: the Rotterdam study. Atherosclerosis. 2004;176:111–116
  15. Abramson JL, Weintraub WS, Vaccarino V. Association between pulse pressure and C-reactive protein among apparently healthy us adults. Hypertension. 2002;39:197–202
  16. Yasmin , McEniery CM, Wallace S, Mackenzie IS, Cockcroft JR, Wilkinson IB. C-reactive protein is associated with arterial stiffness in apparently healthy individuals. Arterioscler Thromb Vasc Biol. 2004;24:969–974
  17. Dupuis J, Larson MG, Vasan RS, Massaro JM, Wilson PW, Lipinska I, et al. Genome scan of systemic biomarkers of vascular inflammation in the Framingham heart study: evidence for susceptibility loci on 1q. Atherosclerosis. 2005;182:307–314
  18. Pankow JS, Folsom AR, Cushman M, Borecki IB, Hopkins PN, Eckfeldt JH, et al. Familial and genetic determinants of systemic markers of inflammation: The NHLBI family heart study. Atherosclerosis. 2001;154:681–689
  19. Gambaro G, Anglani F, D'Angelo A. Association studies of genetic polymorphisms and complex disease. Lancet. 2000;355:308–311
  20. Keavney B, Danesh J, Parish S, Palmer A, Clark S, Youngman L, et al. Fibrinogen and coronary heart disease: Test of causality by ‘Mendelian randomization’. Int J Epidemiol. 2006;35:935–943
  21. Hofman A, Grobbee DE, de Jong PT. van den Ouweland FA. Determinants of disease and disability in the elderly: The Rotterdam elderly study. Eur J Epidemiol. 1991;7:403–422
  22. Stephens M, Smith NJ, Donnelly P. A new statistical method for haplotype reconstruction from population data. Am J Hum Genet. 2001;68:978–989
  23. Hoeks AP, Brands PJ, Smeets FA, Reneman RS. Assessment of the distensibility of superficial arteries. Ultrasound Med Biol. 1990;16:121–128
  24. Kool MJ, van Merode T, Reneman RS, Hoeks AP, Struyker Boudier HA, Van Bortel LM. Evaluation of reproducibility of a vessel wall movement detector system for assessment of large artery properties. Cardiovasc Res. 1994;28:610–614
  25. Reneman RS, van Merode T, Hick P, Muytjens AM, Hoeks AP. Age-related changes in carotid artery wall properties in men. Ultrasound Med Biol. 1986;12:465–471
  26. Anonymous. Report of the expert committee on the diagnosis and classification of diabetes mellitus. Diabetes Care. 1997;20:1183–1197
  27. Bots ML, Hoes AW, Koudstaal PJ, Hofman A, Grobbee DE. Common carotid intima-media thickness and risk of stroke and myocardial infarction: the Rotterdam study. Circulation. 1997;96:1432–1437
  28. Witteman JC, Grobbee DE, Valkenburg HA, van Hemert AM, Stijnen T, Burger H, et al. J-shaped relation between change in diastolic blood pressure and progression of aortic atherosclerosis. Lancet. 1994;343:504–507
  29. Miller DT, Zee RY, Suk Danik J, Kozlowski P, Chasman DI, Lazarus R, et al. Association of common CRP gene variants with CRP levels and cardiovascular events. Ann Hum Genet. 2005;69:623–638
  30. Kardys I, de Maat MP, Uitterlinden AG, Hofman A, Witteman JC. C-reactive protein gene haplotypes and risk of coronary heart disease: the Rotterdam study. Eur Heart J. 2006;27:1331–1337
  31. Carlson CS, Aldred SF, Lee PK, Tracy RP, Schwartz SM, Rieder M, et al. Polymorphisms within the C-reactive protein (CRP) promoter region are associated with plasma CRP levels. Am J Hum Genet. 2005;77:64–77
  32. Schnabel R, Larson MG, Dupuis J, Lunetta KL, Lipinska I, Meigs JB, et al. Relations of inflammatory biomarkers and common genetic variants with arterial stiffness and wave reflection. Hypertension. 2008;51:1651–1657
  33. Venugopal SK, Devaraj S, Jialal I. C-reactive protein decreases prostacyclin release from human aortic endothelial cells. Circulation. 2003;108:1676–1678
  34. Verma S, Wang CH, Li SH, Dumont AS, Fedak PW, Badiwala MV, et al. A self-fulfilling prophecy: C-reactive protein attenuates nitric oxide production and inhibits angiogenesis. Circulation. 2002;106:913–919
  35. Yudkin JS, Stehouwer CD, Emeis JJ, Coppack SW. C-reactive protein in healthy subjects: Associations with obesity, insulin resistance, and endothelial dysfunction: a potential role for cytokines originating from adipose tissue?. Arterioscler Thromb Vasc Biol. 1999;19:972–978
  36. Thorand B, Baumert J, Doring A, Schneider A, Chambless L, Lowel H, et al. Association of cardiovascular risk factors with markers of endothelial dysfunction in middle-aged men and women. Results from the Monica/Kora Augsburg study. Thromb Haemost. 2006;95:134–141
  37. Fichtlscherer S, Rosenberger G, Walter DH, Breuer S, Dimmeler S, Zeiher AM. Elevated C-reactive protein levels and impaired endothelial vasoreactivity in patients with coronary artery disease. Circulation. 2000;102:1000–1006
  38. Hingorani AD, Cross J, Kharbanda RK, Mullen MJ, Bhagat K, Taylor M, et al. Acute systemic inflammation impairs endothelium-dependent dilatation in humans. Circulation. 2000;102:994–999
  39. Vallance P, Collier J, Moncada S. Effects of endothelium-derived nitric oxide on peripheral arteriolar tone in man. Lancet. 1989;2:997–1000
  40. Haynes WG, Noon JP, Walker BR, Webb DJ. Inhibition of nitric oxide synthesis increases blood pressure in healthy humans. J Hypertens. 1993;11:1375–1380
  41. Ramsey MW, Goodfellow J, Jones CJ, Luddington LA, Lewis MJ, Henderson AH. Endothelial control of arterial distensibility is impaired in chronic heart failure. Circulation. 1995;92:3212–3219
  42. Joannides R, Richard V, Haefeli WE, Benoist A, Linder L, Luscher TF, et al. Role of nitric oxide in the regulation of the mechanical properties of peripheral conduit arteries in humans. Hypertension. 1997;30:1465–1470
  43. Wilkinson IB, Qasem A, McEniery CM, Webb DJ, Avolio AP, Cockcroft JR. Nitric oxide regulates local arterial distensibility in vivo. Circulation. 2002;105:213–217
  44. Waddell TK, Dart AM, Medley TL, Cameron JD, Kingwell BA. Carotid pressure is a better predictor of coronary artery disease severity than brachial pressure. Hypertension. 2001;38:927–931
  45. Liu C, Wang S, Deb A, Nath KA, Katusic ZS, McConnell JP, et al. Proapoptotic, antimigratory, antiproliferative, and antiangiogenic effects of commercial C-reactive protein on various human endothelial cell types in vitro: Implications of contaminating presence of sodium azide in commercial preparation. Circ Res. 2005;97:135–143
  46. van den Berg CW, Taylor KE, Lang D. C-reactive protein-induced in vitro vasorelaxation is an artefact caused by the presence of sodium azide in commercial preparations. Arterioscler Thromb Vasc Biol. 2004;24:e168–e171

PII: S1872-9312(08)00507-3

doi: 10.1016/j.artres.2008.10.002

Artery Research
Volume 2, Issue 4 , Pages 148-155 , November 2008

Article Tools

* Image Usage & Resolution